Principal Investigator: Del Miller, PharmD, MD

You may qualify to participate in this study if you:

• Have a diagnosis of schizophrenia or schizoaffective disorder
• Are between the ages of 18-65
• Are currently taking one of the following antipsychotic medications: olanzapine, quetiapine, or risperidone
• Have experienced difficulty with weight management
• Have high cholesterol
• Would like to learn more about participating in a diet and exercise program

The purpose of this study is to evaluate the antipsychotic medications used to treat schizophrenia and schizoaffective disorder. We will look at weight management strategies and possible health problems such as heart disease and diabetes. You will have a 50/50 chance of switching to the study medication, aripiprazole (Abilify), or staying on your current medication.

Compensation is available. Participation is voluntary.

If you have questions or would like more information, please contact:

Tim Holman: 319-335-6769
Jane Kerr: 319-353-4955
Toll-free inquiries may be made through UI Health Access at 800-777-8442.